Page 63 - Read Online

Page 10 of 10 Scotti et al. Vessel Plus 2021;5:6 I http://dx.doi.org/10.20517/2574-1209.2020.68

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Feldman T., Wasserman HS., Herrmann HC., et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results
of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134–40.
2. Puls M., Lubos E., Boekstegers P., et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical
practice: Results from the German transcatheter mitral valve interventions registry. Eur Heart J 2016;37:703–12.
3. Maisano F., Franzen O., Baldus S., et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the
ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the Mitraclip therapy in Europe. J Am Coll Cardiol
2013;62(12):1052–61.
4. Praz F., Spargias K., Chrissoheris M., et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with
severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 2017;390:773–80.
5. Glower DD., Kar S., Trento A., et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: Results of the
EVEREST II study. J Am Coll Cardiol 2014;64:172–81.
6. Lim DS., Reynolds MR., Feldman T., et al. Improved functional status and quality of life in prohibitive surgical risk patients with
degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 2014;64:182–92.
7. Deferm S., Bertrand PB., Verbrugge FH., et al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Coll Cardiol
2019;73:2465–76.
8. Packer M., Grayburn PA. New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate
functional mitral regurgitation. JAMA Cardiol 2020: 469-75.
9. Baumgartner H., Falk V., Bax JJ., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J
2017;38:2739–86.
10. Stone GW., Lindenfeld JA., Abraham WT., et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med
2018;379:2307–18.
11. Obadia JF., Messika-Zeitoun D., Leurent G., et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J
Med 2018;379:2297–306.
12. Bonow RO., O’Gara PT., Adams DH., et al. 2020 focused update of the 2017 ACC expert consensus decision pathway on the
management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll
Cardiol 2020;75:2236–70.
13. Scotti A., Margonato A., Godino C. Percutaneous mitral valve repair in patients with secondary mitral regurgitation and advanced heart
failure. Mini-Invasive Surg 2020;4:49.
14. Godino C., Munafò A., Scotti A., et al. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes
from the International MitraBridge Registry. J Hear Lung Transplant 2020;39:1353–62.
15. Feldman T., Cilingiroglu M. Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J Am Coll Cardiol 2011:529–37.
16. Lubos E., Schlüter M., Vettorazzi E., et al. MitraClip therapy in surgical high-risk patients: Identification of echocardiographic variables
affecting acute procedural outcome. JACC Cardiovasc Interv 2014;7:394–402.
17. Brown JM., O’Brien SM., Wu C., Sikora JAH., Griffith BP., Gammie JS. Isolated aortic valve replacement in North America comprising
108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J
Thorac Cardiovasc Surg 2009;137:82–90.
18. Mylotte D., Andalib A., Thériault-Lauzier P., et al. Transcatheter heart valve failure: a systematic review. Eur Heart J 2015;36:1306–27.
19. Del Val D., Ferreira-Neto AN., Wintzer-Wehekind J., et al. Early experience with transcatheter mitral valve replacement: a systematic
review. J Am Heart Assoc 2019;8:e013332.
20. Taramasso M., Gavazzoni M., Nickenig G., Maisano F. Transcatheter mitral repair and replacement: which procedure for which patient?
EuroIntervention 2019;15:867–74.
21. Adamo M., Godino C., Giannini C., et al. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional
mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail 2018;21:ejhf.1343.
22. Godino C., Salerno A., Cera M., et al. Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in
patients with functional mitral regurgitation. IJC Hear Vasc 2016;11:90–8.
23. Bapat V., Rajagopal V., Meduri C., et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol
2018;71:12–21.
24. Sorajja P., Moat N., Badhwar V., et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll
Cardiol 2019;73(11):1250–60.